Stockscreener 앱 받기
112.50
2.45%
-2.83
시간 외 거래:
112.50
전일 마감가:
$115.33
열려 있는:
$114.83
하루 거래량:
1.60M
Relative Volume:
1.12
시가총액:
$12.75B
수익:
$2.77B
순이익/손실:
$286.61M
주가수익비율:
47.87
EPS:
2.35
순현금흐름:
$524.11M
1주 성능:
+7.73%
1개월 성능:
+16.86%
6개월 성능:
+18.55%
1년 성능:
-5.88%
1일 변동 폭
$111.86
$115.44
1주일 범위
$102.71
$115.78
52주 변동 폭
$81.36
$128.28
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
RVTY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
112.50 | 13.08B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Goldman | Neutral |
| 2025-10-16 | 개시 | Guggenheim | Neutral |
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Surprises Report: Can Revvity Inc outperform in the next rallyJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity Stock Gains On Solid Early Q4 Results, Upbeat Outlook - Sahm
The Bull Case For Revvity (RVTY) Could Change Following Upbeat 2025 Guidance And New Lilly AI Alliance - Yahoo Finance
What's Going On With Revvity Stock Wednesday?Revvity (NYSE:RVTY) - Benzinga
Weekly Trades: Is Revvity Inc showing insider buyingPortfolio Update Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Revvity stock surges on exceeding profit forecasts - MSN
How (RVTY) Movements Inform Risk Allocation Models - Stock Traders Daily
Revvity (NYSE:RVTY) Shares Gap UpHere's Why - MarketBeat
Revvity expects to report Q4 revenue of $772 million - MSN
Revvity Inc expects existing end market trends to continue into 2026presentation - marketscreener.com
Risk Hedge: What dividend safety score for Revvity Inc stock2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Bộ Nội Vụ
Revvity Raises 2025 Outlook With Strong Preliminary Results - TipRanks
Revvity Inc Expect Existing End Market Trends To Continue Into 2026Presentation - TradingView — Track All Markets
Stock Market Today: Nasdaq 100, S&P 500, Dow Jones Futures Lag Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus (UPDATED) - Benzinga
S&P 500 Futures Decline in Premarket Trading; L3Harris Technologies, Revvity Lead - Barron's
Revvity (NYSE:RVTY) Issues FY 2025 Earnings Guidance - MarketBeat
Revvity Stock Pre-Market (+4.9%): Exceeds Top-End of EPS and Revenue Guidance - Trefis
Why Is RVTY Stock Surging in Premarket? Q4 Revenue Outlook Tops Expectations - Tokenist
Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads. - Barron's
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance - PharmiWeb.com
Revvity says it will exceed 2025 profit forecast range - MSN
Revvity sale, perché la società prevede di superare le previsioni di profitto per il 2025 - TradingView — Track All Markets
Revvity rises as co expects to exceed 2025 profit forecast - TradingView — Track All Markets
Revvity Preliminary Q4 Revenue Tops Estimates; Shares Rise After Hours - marketscreener.com
RVTY Stock Shows Positive Outlook with Analyst Consensus - GuruFocus
Revvity (RVTY) Sees Stock Uptick After Q4 Revenue Announcement - GuruFocus
RVTY Projects Revenue Growth for Q4 and 2025 - GuruFocus
Revvity expects to exceed Q4 guidance with 6% revenue growth - Investing.com
Revvity expects to exceed Q4 guidance with 6% revenue growth By Investing.com - Investing.com India
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models - TradingView — Track All Markets
Revvity collaborates with Eli Lilly to expand access to AI drug discovery models - BioSpectrum Asia
Why Revvity (RVTY) Is Up 6.4% After New Lilly AI Drug Discovery Partnership Integration - simplywall.st
Revvity's (NYSE:RVTY) Earnings Trajectory Could Turn Positive as the Stock Climbs 6.4% This Past Week - 富途牛牛
Revvity and Lilly partner to accelerate AI drug discovery models - Indian Pharma Post
About Us | Laser Focus WorldRevvity, Inc. Common Stock (NYSE:RVTY) Price Chart - FinancialContent
Key facts: Eli Lilly to acquire Ventyx for $1.2B; Mounjaro pricing in India; AI partnership with Revvity - TradingView — Track All Markets
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models - PharmiWeb.com
Revvity, Inc. Collaborates with Eli Lilly and Company to Expand Access to Ai Drug Discovery Models - marketscreener.com
Eli Lilly in pact with Schrödinger, Revvity for AI-driven drug discovery - Seeking Alpha
Revvity collaborates with Lilly to expand access to AI drug discovery models - marketscreener.com
Revvity announces collaboration with Eli Lilly on AI drug discovery models - TipRanks
Revvity, Lilly Partner To Expand Access To AI Drug Discovery Models - Nasdaq
Revvity (NYSE:RVTY) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 5.1% this past week - simplywall.st
Will Revvity Inc. (PKN) stock outperform global peersJuly 2025 Action & High Conviction Investment Ideas - ulpravda.ru
Can Revvity Inc. (PKN) stock ride next bull market cycle2025 Volume Leaders & High Conviction Trade Alerts - ulpravda.ru
Is Revvity Inc. stock a good choice for value investorsJuly 2025 Short Interest & High Yield Equity Trading Tips - ulpravda.ru
Revvity Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Is Revvity Inc. (PKN) stock a buy on weakness2025 Retail Activity & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Will Revvity Inc. stock reach all time highs in 2025Market Risk Report & Weekly Watchlist for Hot Stocks - ulpravda.ru
Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
0.74%
자본화:
|
볼륨(24시간):